Mucosal Immunity
34.5K views | +4 today
Mucosal Immunity
The largest immune tissue in the body
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
February 15, 2017 8:23 AM
Scoop.it!

Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?

Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy? | Mucosal Immunity | Scoop.it
IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. Lifelong mesangial deposition of IgA1 complexes subsist inflammation and nephron loss, but the complex pathogenesis i
No comment yet.
Scooped by Gilbert C FAURE
February 14, 2017 8:56 AM
Scoop.it!

Single-cell Analysis of Bacillus subtilis Biofilms Using Fluorescence Microscopy and Flow Cytometry | Protocol

Single-cell Analysis of Bacillus subtilis Biofilms Using Fluorescence Microscopy and Flow Cytometry | Protocol | Mucosal Immunity | Scoop.it
Microbial biofilms are generally constituted by distinct subpopulations of specialized cells. Single-cell analysis o
No comment yet.
Scooped by Gilbert C FAURE
February 13, 2017 1:33 PM
Scoop.it!

Efficacy and safety of calcineurin inhibitor treatment for IgA nephropathy: a meta-analysis

Efficacy and safety of calcineurin inhibitor treatment for IgA nephropathy: a meta-analysis | Mucosal Immunity | Scoop.it
IgA nephropathy is the most common progressive glomerular disease to end stage renal failure worldwide. Calcineurin inhibitors (CNIs) is a selective immunosuppressant widely used in organ transplantation. The efficacy and safety of calcineurin inhibitors for the treatment of IgA nephropathy remain uncertain. We performed a systematic literature search using the PubMed, Embase, Science Citation Index, Ovid evidence-based medicine, Chinese Biomedical Literature (CBM) and Chinese science and technology periodicals (CNKI, VIP, and Wan Fang) for randomized, controlled trials of CNIs therapy of IgA nephropathy. Complete remission rate (CR) was defined as proteinuria less than 0.5 or 0.3 g/d. Partial remission rate (PR) was defined as proteinuria reduced to at least half of the baseline measurement and an absolute value of >0.5 or 0.3 g/d. Seven relevant trials were conducted with 374 patients enrolled. CNIs plus medium/low-dose steroid had a higher CR (RR = 2.51 [95% CI,1.25 to 5.04], P = 0.02) compared to therapy with steroid alone or placebo, but were not significant on PR (RR = 0.87 [95% CI,0.32 to 2.38]; P = 0.78). Also, significant alterations were observed in proteinuria (weighted mean difference, −0.46 g/d,[95% CI:-0.55 to −0.24], P < 0.01) with no differences were found in serum creatinine (SCr) (weighted mean difference, 0.57,95% CI:-4.05 to 5.19; P = 0.78) and estimated glomerular filtration rate (eGFR) (weighted mean difference, 1.13,95% CI:-4.05 to 6.32; P = 0.34) level between the two groups. CNI therapy was associated with an increased risk for adverse events (RR = 2.21,95% CI:1.52 to 3.21, P < 0.01), such as gastrointestinal and neurological symptoms or hirsutism. CNIs might provide renal protection in patients with IgAN, but at an increased risk of adverse events. Reliably defining the efficacy and safety of CNIs in IgAN requires a high-quality trial with a large sample size.
No comment yet.
Scooped by Gilbert C FAURE
February 13, 2017 9:42 AM
Scoop.it!

Crosstalk at the mucosal border: importance of the gut microenvironment in IBS

Nature Reviews Gastroenterology and Hepatology | doi:10.1038/nrgastro.2014.200
No comment yet.
Scooped by Gilbert C FAURE
February 13, 2017 7:05 AM
Scoop.it!

Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women

Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women | Mucosal Immunity | Scoop.it
The potential impact of cervicovaginal bacteria on HIV susceptibility is not well-defined.
Gosmann et al. (2017) identify anaerobic cervicovaginal bacterial communities and
specific taxa highly prevalent in young healthy South African women that increase
their HIV risk. These findings might be leveraged to reduce HIV acquisition in women.
No comment yet.
Scooped by Gilbert C FAURE
February 12, 2017 11:28 AM
Scoop.it!

The role of mucosal‐associated invariant T cells in infectious diseases

The role of mucosal‐associated invariant T cells in infectious diseases | Mucosal Immunity | Scoop.it
Mucosal‐associated invariant T (MAIT) cells are donor‐unrestricted lymphocytes that are surprisingly abundant in humans, representing 1–10% of circulating T cells and further enriched in mucosa
Gilbert C FAURE's insight:
Summary Mucosal-associated invariant T (MAIT) cells are donor-unrestricted lymphocytes that are surprisingly abundant in humans, representing 1–10% of circulating T cells and further enriched in mucosal tissues. MAIT cells recognize and are activated by small molecule ligands produced by microbes and presented by MR1, a highly conserved MHC-related antigen-presenting protein that is ubiquitously expressed in human cells. Increasing evidence suggests that MAIT cells play a protective role in anti-bacterial immunity at mucosal interfaces. Some fungi are known to produce MAIT-activating ligands, but the role of MAIT cells in fungal infections has not yet been investigated. In viral infections, specifically HIV, which has received the most study, MAIT cell biology is clearly altered, but the mechanisms explaining these alterations and their clinical significance are not yet understood. Many questions remain unanswered about the potential of MAIT cells for protection or pathogenesis in infectious diseases. Because they interact with the universal, donor-unrestricted ligand-presenting MR1 molecule, MAIT cells may be attractive immunotherapy or vaccine targets. New tools, including the development of MR1-ligand tetramers and next-generation T-cell receptor sequencing, have the potential to accelerate MAIT cell research and lead to new insights into the role of this unique set of lymphocytes in infectious diseases.
No comment yet.
Scooped by Gilbert C FAURE
February 11, 2017 1:27 PM
Scoop.it!

Genetic variants alter T-bet binding and gene expression in mucosal inflammatory disease

Genetic variants alter T-bet binding and gene expression in mucosal inflammatory disease | Mucosal Immunity | Scoop.it
Author summary Research to date has identified many genetic variants that are more common in people with a particular disease. However, in conditions that reflect multiple genetic and environmental factors, it is difficult to know with certainty if and why any particular genetic variant is causative and the mechanism that may underlie this. Such variants are often outside of protein-coding exons, instead falling in regions that regulate gene expression. In these cases, the genetic variation may alter transcription factor binding and subsequent gene expression. In this study, we have examined how genetic variation affects T-bet binding to DNA, as a key transcriptional regulatory mechanism in the immune response. An inability to mount this response effectively can result in increased susceptibility to infections or cancer, while a response that is too strong, or wrongly targeted, can result in uncontrolled/chronic inflammatory and autoimmune conditions. We have found that T-bet binding sites are specifically enriched in genetic variants associated with the mucosal autoinflammatory diseases UC, Crohn’s disease and celiac disease. We also identify genetic variants that alter T-bet binding and gene expression. This discovery thus identifies a molecular mechanism through which genetic variants can be associated with increased risk of mucosal autoimmune disease.
No comment yet.
Scooped by Gilbert C FAURE
February 11, 2017 1:26 PM
Scoop.it!

GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway

GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway | Mucosal Immunity | Scoop.it
Author summary O-glycosylation is a common type of post-translational modification of proteins; specific abnormalities in the mechanism of O-glycosylation have been implicated in cancer, inflammatory and blood diseases. However, the molecular basis of abnormal O-glycosylation in these complex disorders is not known. We studied the genetic basis of defective O-glycosylation of serum immunoglobulin A1 (IgA1), that represents the key pathogenic defect in IgA nephropathy, the most common form of primary glomerulonephritis worldwide. We report our results of the first genome-wide association study for this trait using serum assays in 2,633 individuals of European and East-Asian ancestry. In our genome scan, we observed two significant signals with large effects, on chromosomes 7p21.3 and Xq24, jointly explaining about 7% of trait variability. These signals implicate two genes that encode molecular partners essential for enzymatic O-glycosylation of IgA1 and mucins, and represent potential new targets for therapy.
No comment yet.
Scooped by Gilbert C FAURE
February 11, 2017 12:23 PM
Scoop.it!

The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts

The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts | Mucosal Immunity | Scoop.it
Publication date: February 2017
Source:Drug Discovery Today, Volume 22, Issue 2
Author(s): Nicolau B. da Cunha, Nicole B. Cobacho, Juliane F.C. Viana, Loiane A. Lima, Kamila B.O. Sampaio, Stephan S.M. Dohms, Arthur C.R. Ferreira, César de la Fuente-Núñez, Fabrício F. Costa, Octávio L. Franco, Simoni C. Dias
Anti-infective drugs have had a key role in the contemporary world, contributing to dramatically decrease mortality rates caused by infectious diseases worldwide. Antimicrobial peptides (AMPs) are multifunctional effectors of the innate immune system of mucosal surfaces and present antimicrobial activity against a range of pathogenic viruses, bacteria, and fungi. However, the discovery and development of new antibacterial drugs is a crucial step to overcome the great challenge posed by the emergence of antibiotic resistance. In this review, we outline recent advances in the development of novel AMPs with improved antimicrobial activities that were achieved through characteristic structural design. In addition, we describe recent progress made to overcome some of the major limitations that have hindered peptide biosynthesis.
Teaser This review provides an integrated scenario of the most relevant aspects in the development of useful drugs provided by natural sources and recent advances in the biosynthesis and structural design of antimicrobial peptides.
No comment yet.
Scooped by Gilbert C FAURE
February 9, 2017 6:48 AM
Scoop.it!

Studies of Tonsils in Basic and Clinical Perspectives: From the Past to the Future. - PubMed - NCBI

Studies of Tonsils in Basic and Clinical Perspectives: From the Past to the Future. - PubMed - NCBI | Mucosal Immunity | Scoop.it
Adv Otorhinolaryngol. 2016;77:119-24. doi: 10.1159/000441902. Epub 2016 Apr 26. Review
No comment yet.
Scooped by Gilbert C FAURE
February 9, 2017 5:01 AM
Scoop.it!

Decreased Serum C3 Levels in Immunoglobulin A (IgA) Nephropathy with Chronic Kidney Disease: A Propensity Score Matching Study. - PubMed - NCBI

Decreased Serum C3 Levels in Immunoglobulin A (IgA) Nephropathy with Chronic Kidney Disease: A Propensity Score Matching Study. - PubMed - NCBI | Mucosal Immunity | Scoop.it
Med Sci Monit. 2017 Feb 6;23:673-681.
Gilbert C FAURE's insight:
??
No comment yet.
Scooped by Gilbert C FAURE
February 7, 2017 5:17 AM
Scoop.it!

Is adaptive-innate lymphocyte cross-talk driving mucosal disease?

National Academy of Sciences
No comment yet.
Scooped by Gilbert C FAURE
February 7, 2017 5:15 AM
Scoop.it!

Unearthing immune responses to common drugs

Unearthing immune responses to common drugs | Mucosal Immunity | Scoop.it
Australian researchers are a step closer to understanding immune sensitivities to well-known, and commonly prescribed, medications.
Gilbert C FAURE's insight:
published overnight!
No comment yet.
Scooped by Gilbert C FAURE
February 15, 2017 4:33 AM
Scoop.it!

Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice

Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice | Mucosal Immunity | Scoop.it
Autoantigen-specific immunological tolerance represents a central objective for prevention of type 1 diabetes (T1D).
No comment yet.
Scooped by Gilbert C FAURE
February 14, 2017 8:55 AM
Scoop.it!

Novel flow cytometry approach to identify bronchial epithelial cells from healthy human airways

Novel flow cytometry approach to identify bronchial epithelial cells from healthy human airways | Mucosal Immunity | Scoop.it
Sampling various compartments within the lower airways to examine human bronchial epithelial cells (HBEC) is essential for understanding numerous lung diseases.
No comment yet.
Scooped by Gilbert C FAURE
February 13, 2017 1:33 PM
Scoop.it!

Human Lung Dendritic Cells: Spatial Distribution and Phenotypic Identification in Endobronchial Biopsies Using Immunohistochemistry and Flow Cytome... - PubMed - NCBI

Human Lung Dendritic Cells: Spatial Distribution and Phenotypic Identification in Endobronchial Biopsies Using Immunohistochemistry and Flow Cytome... - PubMed - NCBI | Mucosal Immunity | Scoop.it
J Vis Exp. 2017 Jan 20;(119). doi: 10.3791/55222.
No comment yet.
Scooped by Gilbert C FAURE
February 13, 2017 9:39 AM
Scoop.it!

The ASI-Visiting Speaker Program (VSP) | Australasian Society for Immunology |

The ASI-Visiting Speaker Program (VSP) | Australasian Society for Immunology | | Mucosal Immunity | Scoop.it
Visiting Prof Haigwood discussing “Antibodies as Change Agents in HIV: Good News for Vaccines"at seminars around AUS
https://t.co/4hYd1p1zqt https://t.co/2xTNdKabh3
No comment yet.
Scooped by Gilbert C FAURE
February 13, 2017 6:56 AM
Scoop.it!

CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes

National Academy of Sciences
No comment yet.
Scooped by Gilbert C FAURE
February 12, 2017 3:49 AM
Scoop.it!

Chronic Inflammation in CF Airways - A Persistent Issue for A20

Chronic Inflammation in CF Airways - A Persistent Issue for A20 | Mucosal Immunity | Scoop.it
Cystic Fibrosis (CF) is characterised by prolonged and exaggerated airways inflammation. Despite recent developments to overcome the underlying functional defect in CFTR ..
No comment yet.
Scooped by Gilbert C FAURE
February 11, 2017 1:27 PM
Scoop.it!

New developments and directions in the clinical application of the echinocandins. - PubMed - NCBI

New developments and directions in the clinical application of the echinocandins. - PubMed - NCBI | Mucosal Immunity | Scoop.it
Arch Toxicol. 2017 Feb 8. doi: 10.1007/s00204-016-1916-3. [Epub ahead of print] Review
No comment yet.
Scooped by Gilbert C FAURE
February 11, 2017 12:23 PM
Scoop.it!

ScienceDirect

Publication date: December 2016
Source:Medical Hypotheses, Volume 97
Author(s): Elham Sadat Mirfazeli, Sayed-Amir Marashi, Shiva Kalantari
IgA nephropathy is one of the most common forms of primary glomerulonephritis worldwide leading to end-stage renal disease. Proliferation of mesangial cells, i.e., the multifunctional cells located in the intracapillary region of glomeruli, after IgA- dominant immune deposition is the major histologic feature in IgA nephropathy. In spite of several studies on molecular basis of proliferation in these cells, specific pathways responsible for regulation of proliferation are still to be discovered. In this study, we predicted a specific signaling pathway started from transferrin receptor (TFRC), a specific IgA1 receptor on mesangial cells, toward a set of proliferation-related proteins. The final constructed subnetwork was presented after filtration and evaluation. The results suggest that estrogen receptor (ESR1) as a hub protein in the significant subnetwork has an important role in the mesangial cell proliferation and is a potential target for IgA nephropathy therapy. In conclusion, this study suggests a novel hypothesis for the mechanism of pathogenesis in IgA nephropathy and is a reasonable start point for the future experimental studies on mesangial proliferation process in this disease.
No comment yet.
Rescooped by Gilbert C FAURE from Immunology, vaccine & infectious diseases
February 10, 2017 7:02 AM
Scoop.it!

Mucosal Immunology - IL-36[gamma] is a crucial proximal component of protective type-1-mediated lung mucosal immunity in Gram-positive and -negative bacterial pneumonia

Mucosal Immunology - IL-36[gamma] is a crucial proximal component of protective type-1-mediated lung mucosal immunity in Gram-positive and -negative bacterial pneumonia | Mucosal Immunity | Scoop.it
Mucosal Immunology is the official publication of the Society of Mucosal Immunology (SMI). It aims to provide a forum for both basic and clinical scientists to discuss all aspects of immunity and inflammation involving mucosal tissues. The journal reflects the interests of scientists studying gastrointestinal, pulmonary, nasopharyngeal, oral, ocular, and genitourinary immunology through the publication of original research articles, scholarly reviews, and timely commentaries, editorials and letters.

Via Denis Hudrisier
Denis Hudrisier's curator insight, February 8, 2017 1:45 PM
A new player in lung immunity to bacteria
Scooped by Gilbert C FAURE
February 9, 2017 5:05 AM
Scoop.it!

The mucosal immune system: master regulator of bidirectional gut–brain communications

Nick Powell, Marjorie M. Walker & Nicholas J. Talley AffiliationsContributionsCorresponding author Nature Reviews Gastroenterology & Hepatology (2017) doi:10.1038/nrgastro.2016.191 Published online 18 January 2017
Gilbert C FAURE's insight:
Communication between the brain and gut is not one-way, but a bidirectional highway whereby reciprocal signals between the two organ systems are exchanged to coordinate function. The messengers of this complex dialogue include neural, metabolic, endocrine and immune mediators responsive to diverse environmental cues, including nutrients and components of the intestinal microbiota (microbiota–gut–brain axis). We are now starting to understand how perturbation of these systems affects transition between health and disease. The pathological repercussions of disordered gut–brain dialogue are probably especially pertinent in functional gastrointestinal diseases, including IBS and functional dyspepsia. New insights into these pathways might lead to novel treatment strategies in these common gastrointestinal diseases. In this Review, we consider the role of the immune system as the gatekeeper and master regulator of brain–gut and gut–brain communications. Although adaptive immunity (T cells in particular) participates in this process, there is an emerging role for cells of the innate immune compartment (including innate lymphoid cells and cells of the mononuclear phagocyte system). We will also consider how these key immune cells interact with the specific components of the enteric and central nervous systems, and rapidly respond to environmental variables, including the microbiota, to alter gut homeostasis.
No comment yet.
Scooped by Gilbert C FAURE
February 9, 2017 4:56 AM
Scoop.it!

Excessive antibiotic use in newborns can permanently damage lungs' defenses

Doctors have long understood that antibiotics that protect infants from infection also can disrupt the normal growth of their gut bacteria. However, a new study reveals that the consequences of routine antibiotic use may be deeper and longer lasting than expected. The study, published Feb. 8 in Science Translational Medicine, shows that short-term disruption of gut bacteria makes infant mice more likely to develop pneumonia. It also makes them more likely to die from it.
Gilbert C FAURE's insight:
Specifically, the presence of commensal bacteria triggers the production of group 3 innate lymphoid cells (ILC3). These sentinel cells migrate to mucosal linings in the lungs, where they produce Interleukin-22 (IL-22). This vital signaling protein helps activate the immune response to infection. The problem is when antibiotics wipe out good bacteria, they cut off that important flow of signals. As a result, the lungs build weaker castle walls with fewer guards on duty.
No comment yet.
Scooped by Gilbert C FAURE
February 7, 2017 5:17 AM
Scoop.it!

JCI - Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis

Congenital tufting enteropathy (CTE) is a severe autosomal recessive human diarrheal disorder with characteristic intestinal epithelial dysplasia. CTE can be caused by mutations in genes encoding EpCAM, a putative adhesion molecule, and HAI-2, a cell surface protease inhibitor. A similar phenotype occurs in mice whose intestinal epithelial cells (IECs) fail to express the tight junction–associated protein claudin-7. EpCAM stabilizes claudin-7 in IECs, and HAI-2 regulates the cell surface serine protease matriptase, a known modifier of intestinal epithelial physiology. Therefore, we hypothesized that HAI-2, matriptase, EpCAM, and claudin-7 were functionally linked. Herein we have demonstrated that active matriptase cleaves EpCAM after Arg80 and that loss of HAI-2 in IECs led to unrestrained matriptase activity and efficient cleavage of EpCAM. Cleavage of EpCAM decreased its ability to associate with claudin-7 and targeted it for internalization and lysosomal degradation in conjunction with claudin-7. CTE-associated HAI-2 mutant proteins exhibited reduced ability to inhibit matriptase and also failed to efficiently stabilize claudin-7 in IECs. These results identify EpCAM as a substrate of matriptase and link HAI-2, matriptase, EpCAM, and claudin-7 in a functionally important pathway that causes disease when it is dysregulated.
No comment yet.